{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:15:08Z","timestamp":1772590508044,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["KL2TR002241"],"award-info":[{"award-number":["KL2TR002241"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA196692"],"award-info":[{"award-number":["R01CA196692"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cgh.2019.09.033","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T01:55:50Z","timestamp":1570154150000},"page":"1197-1206.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection"],"prefix":"10.1016","volume":"18","author":[{"given":"Elliot B.","family":"Tapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela K.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar K.","family":"Waljee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.09.033_bib1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.09.033_bib2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2018.03.022","article-title":"Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for HCV infection","volume":"154","author":"El-Sherif","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.09.033_bib3","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.09.033_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.09.033_bib5","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2019.09.033_bib6","first-page":"CD012143","article-title":"Direct-acting antivirals for chronic hepatitis C","volume":"6","author":"Jakobsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2019.09.033_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mayocp.2015.03.003","article-title":"Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy","author":"Tapper","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2019.09.033_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.23128","article-title":"Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.09.033_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.amjmed.2018.01.026","article-title":"Increased morbidity and mortality associated with falls among patients with cirrhosis","volume":"131","author":"Ezaz","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2019.09.033_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/apt.14021","article-title":"Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents","volume":"45","author":"Moon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.09.033_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.27366","article-title":"Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus","volume":"61","author":"Yoshida","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.09.033_bib13","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182688d2f","article-title":"Use of administrative claims data for identifying patients with cirrhosis","volume":"47","author":"Nehra","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2019.09.033_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.29628","article-title":"A\u00a0risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis","volume":"68","author":"Tapper","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.09.033_bib15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.09.033_bib16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.09.033_bib17","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/hep.29756","article-title":"Patient reported outcomes\u00a0in cirrhosis: a scoping review of the literature","volume":"67","author":"Tapper","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.09.033_bib18","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis","volume":"48","author":"Arguedas","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2019.09.033_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","article-title":"Rates of and Reasons for Hospital Readmissions in Patients with Cirrhosis: A Multistate Population-based Cohort Study","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.09.033_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.09.033_bib21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cgh.2015.03.019","article-title":"Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosis","volume":"13","author":"Tapper","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.09.033_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.09.033_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cid\/ciz243","article-title":"Not achieving sustained viral eradication of hepatitis C virus after treatment leads to worsening patient-reported outcomes","volume":"7","author":"Younossi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2019.09.033_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.24383","article-title":"Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients\u00a0awaiting liver transplantation","volume":"22","author":"Carrion","year":"2016","journal-title":"Liver Transpl"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519310821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519310821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:29:59Z","timestamp":1761542999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519310821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1542356519310821"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.09.033","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}